Applied Clinical Trials April 2022 Issue (PDF)

Five proactive steps industry can take to optimize a patient's clinical trial experience.

In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.

GSK’s gepotidacin achieved a 92.6% microbiological success rate in its third positive pivotal trial.

In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.

Reviva Pharmaceuticals and the FDA have reached alignment on the 4-week global registrational study.

Cross-sectional study observed responses to cancer care questions generated by artificial intelligence.